
This is a PDF download licensed for personal use only - read full licence terms.
By placing your order you agree to the British Psychological Society’s Terms and Conditions. Please also see our Privacy Notice and Cookies Information.
This guidance has been written for commissioners and policy makers to better understand the benefits of investing in clinical neuropsychology services.
It is relevant to CCGs, Trusts, Health and Wellbeing Boards commissioning services in the following areas:
- Care for long-term neurological conditions such as stroke, epilepsy, dementia, multiple sclerosis, Parkinson's disease, neurodisability and motor neurone disease.
- Care for patients following traumatic or acquired brain injury.
- Inpatient neurosurgery, neurology and neurological rehabilitation.
- Neuro-oncology.
- Outpatient neurological rehabilitation.
- Care for functional neurological disorders such as non-epileptic attack disorder.
Where there is a good neuropsychology service, patients with a wide range of neurological conditions, such as brain injury, epilepsy and stroke, benefit from specialist care for the cognitive and behavioural impact of their condition. This care improves quality of life for patients, maximises chances of recovery and leads to better outcomes, which in turn deliver savings for health and other services.
Contents
- Guidance to Commissioners
- Understanding clinical neuropsychology
- The clinical benefits of commissioning neuropsychology services
- The economic benefits of commissioning neuropsychology services
- The importance of neuropsychology - A patient perspective
- Neuropsychology Â- meeting outcome targets and indicators
- Clinical neuropsychologists are integral to a multi-disciplinary team
- Clinical neuropsychology training and practice
- Conclusions
Appendix - Information on staffing levels for clinical neuropsychology services
References
Series:
SKU: PUB-CAT-1730